EastWest Bioscience Inc. HBOSF
Trading inactive
Finances
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Revenue | 627.267 K -32.01 % | 922.559 K -33.96 % | 1.397 M |
| Net income | -1.607 M -42.00 % | -1.132 M 69.13 % | -3.667 M |
| Income before tax | -1.640 M -47.93 % | -1.109 M 69.68 % | -3.657 M |
| Income before tax ratio | -2.61 -117.57 % | -1.20 54.09 % | -2.62 |
| EBITDA | -1.649 M 4.71 % | -1.731 M 44.78 % | -3.134 M |
| Net income ratio | -2.56 -108.85 % | -1.23 53.26 % | -2.62 |
| Ratio EBITDA | -2.63 -40.15 % | -1.88 16.39 % | -2.24 |
| Gross profit ratio | 0.05 -58.91 % | 0.11 -56.85 % | 0.25 |
| Weighted average shs out dil | 94.729 M 13.08 % | 83.771 M 5.92 % | 79.089 M |
| Weighted average shs out | 94.729 M 13.08 % | 83.771 M 5.92 % | 79.089 M |
| EPS diluted | -0.02 -25.67 % | -0.01 70.80 % | -0.05 |
| Earnings per share | -0.02 -25.67 % | -0.01 70.80 % | -0.05 |
| Gross profit | 28.311 K -72.06 % | 101.341 K -71.50 % | 355.611 K |
| Income tax expense | -32.978 K -243.01 % | 23.061 K 139.16 % | 9.642 K |
| Cost of revenue | 598.956 K -27.06 % | 821.218 K -21.13 % | 1.041 M |
| General and administrative expenses | 2.377 M 30.08 % | 1.827 M -45.91 % | 3.378 M |
| Selling and marketing expenses | 99.609 K 97.83 % | 50.351 K -54.18 % | 109.900 K |
| Other expenses | 0.000 100.00 % | -14.415 K 76.54 % | -61.445 K |
| Operating expenses | 2.249 M 17.66 % | 1.911 M -47.28 % | 3.626 M |
| Cost and expenses | 2.848 M 4.22 % | 2.733 M -41.45 % | 4.667 M |
| Research and development expenses | 11.444 K 330.19 % | 2.660 K -63.51 % | 7.290 K |
| Selling general and administrative expenses | 2.225 M 18.47 % | 1.878 M -46.17 % | 3.488 M |
| Interest income | 0.000 | 0.000 | 0.000 |
| Interest expense | 257.285 K 15.18 % | 223.372 K -13.85 % | 259.280 K |
| Depreciation and amortization | 118.623 K -6.35 % | 126.669 K -7.01 % | 136.218 K |
| Operating income | -2.221 M -22.68 % | -1.810 M 44.65 % | -3.270 M |
| Operating income ratio | -3.54 -80.44 % | -1.96 16.19 % | -2.34 |
| Total other income expenses net | 7.969 K -94.87 % | 155.332 K 122.03 % | -705.041 K |
| 2021 | 2020 | 2019 |
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Net debt | 1.363 M -36.93 % | 2.161 M 14.29 % | 1.891 M |
| Total investments | 54.287 K 105.43 % | 26.426 K -72.45 % | 95.937 K |
| Total debt | 2.420 M 6.70 % | 2.268 M 16.56 % | 1.946 M |
| Accumulated other comprehensive income loss | 470.869 K -21.16 % | 597.284 K 16.78 % | 511.441 K |
| Retained earnings | -9.748 M -4.66 % | -9.314 M -13.25 % | -8.224 M |
| Common stock | 8.842 M 1.98 % | 8.671 M 4.22 % | 8.320 M |
| Total equity | -61.970 K -35.71 % | -45.663 K -107.52 % | 607.414 K |
| Other non current liabilities | 0.000 100.00 % | -74.580 K | 0.000 |
| Long term debt | 368.816 K 25.34 % | 294.255 K 31.11 % | 224.430 K |
| Total non current liabilities | 368.816 K 67.89 % | 219.675 K 28.53 % | 170.909 K |
| Other current liabilities | 1.452 M 318.23 % | -665.504 K -190.88 % | 732.299 K |
| Deferred revenue | 8.264 K -86.73 % | 62.280 K -28.14 % | 86.672 K |
| Short term debt | 2.051 M -4.74 % | 2.153 M -18.34 % | 2.636 M |
| Total current liabilities | 3.425 M 13.83 % | 3.009 M -0.11 % | 3.012 M |
| Total liabilities | 3.794 M 17.50 % | 3.228 M 1.43 % | 3.183 M |
| Other non current assets | -0.524 -203.89 % | 0.505 -99.99 % | 7.282 K |
| Long term investments | 54.287 K 105.43 % | 26.426 K -72.45 % | 95.937 K |
| Intangible assets | 193.921 K -13.70 % | 224.715 K 145.54 % | 91.519 K |
| GoodWill | 0.000 | 0.000 | 0.000 |
| Goodwill and intangible assets | 193.921 K -13.70 % | 224.715 K 145.54 % | 91.519 K |
| Property plant equipment net | 2.128 M -5.04 % | 2.241 M -4.99 % | 2.359 M |
| Total non current assets | 2.377 M -4.65 % | 2.492 M -2.40 % | 2.554 M |
| Other current assets | 18.520 K -82.45 % | 105.549 K -44.80 % | 191.225 K |
| Short term investments | 0.000 | 0.000 -100.00 % | 8.430 |
| cash and cash equivalents | 1.057 M 887.35 % | 107.052 K 94.39 % | 55.072 K |
| Cash and short term investments | 1.057 M 887.35 % | 107.052 K 94.39 % | 55.072 K |
| Total current assets | 1.355 M 96.27 % | 690.356 K -44.17 % | 1.236 M |
| Inventory | 205.244 K -2.75 % | 211.050 K -65.54 % | 612.470 K |
| Net receivables | 82.443 K -73.56 % | 311.829 K -31.66 % | 456.261 K |
| Tax assets | 0.524 -37.13 % | 0.834 -39.11 % | 1.370 |
| Other assets | 1.250 801 282 051 182.05 % | 0.000 | 0.000 |
| Account payables | 498.265 K -9.37 % | 549.782 K -8.67 % | 601.994 K |
| Tax payables | 38.568 K 137.46 % | 16.242 K | 0.000 |
| Deferred revenue non current | 0.000 | 0.000 | 0.000 |
| Minority interest | 372.879 K | 0.000 | 0.000 |
| Capital lease obligations | 0.000 100.00 % | -590.481 K -293.02 % | 305.924 K |
| Preferred stock | 0.000 | 0.000 | 0.000 |
| Other total stockholders equity | 2.426 M -23.28 % | 3.162 M | 0.000 |
| Deferred tax liabilities non current | 0.000 | 0.000 | 0.000 |
| Other liabilities | 1.250 | 0.000 -100.00 % | 1.320 |
| Total assets | 3.732 M 17.24 % | 3.183 M -16.03 % | 3.790 M |
| 2021 | 2020 | 2019 |
| 2021 | 2020 | 2019 | |
|---|---|---|---|
| Deferred income tax | 243.348 K -55.74 % | 549.778 K 229.60 % | -424.219 K |
| Stock based compensation | 232.900 K 135.79 % | 98.775 K -77.65 % | 441.980 K |
| Change in working capital | 715.468 K -28.23 % | 996.954 K 320.80 % | 236.919 K |
| Accounts receivables | 272.657 K 4 509.66 % | -6.183 K 90.49 % | -65.008 K |
| Inventory | 6.107 K -98.08 % | 318.730 K 88.46 % | 169.127 K |
| Accounts payables | 434.728 K -26.24 % | 589.343 K 216.73 % | 186.074 K |
| Other working capital | 1.975 K -97.92 % | 95.064 K 278.45 % | -53.274 K |
| Other non cash items | -392.340 K 59.33 % | -964.687 K -217.71 % | 819.562 K |
| Net cash provided by operating activities | -689.247 K -112.51 % | -324.337 K 86.80 % | -2.456 M |
| Investments in property plant and equipment | -9.469 K -656.51 % | -1.252 K 95.43 % | -27.397 K |
| Acquisitions net | 30.513 K -67.59 % | 94.140 K 124.98 % | -376.813 K |
| Purchases of investments | 0.000 100.00 % | -25.748 K | 0.000 |
| Sales maturities of investments | 0.000 100.00 % | -0.432 | 0.000 |
| Other investing activites | 0.501 5 143 429 158 210.88 % | 0.000 -100.00 % | 153.177 K |
| Net cash used for investing activites | 21.045 K -68.66 % | 67.140 K 126.75 % | -251.033 K |
| Debt repayment | 268.393 61.52 % | 166.169 -38.15 % | 268.653 |
| Common stock issued | 1.283 M 1 375.03 % | 86.957 K -90.94 % | 959.569 K |
| Common stock repurchased | 0.000 | 0.000 | 0.000 |
| Dividends paid | 0.000 | 0.000 | 0.000 |
| Other financing activites | 1.283 K -99.59 % | 309.233 K -78.87 % | 1.463 M |
| Net cash used provided by financing activities | 1.618 M 422.84 % | 309.456 K -78.86 % | 1.464 M |
| Effect of forex changes on cash | -0.189 71.88 % | -0.673 42.50 % | -1.170 |
| Net change in cash | 957.070 K 1 770.67 % | 51.162 K 119.70 % | -259.651 K |
| Cash at beginning of period | 99.910 K 78.76 % | 55.890 K -82.24 % | 314.723 K |
| Cash at end of period | 1.057 M 887.35 % | 107.052 K 94.39 % | 55.072 K |
| Operating cash flow | -689.247 K -112.51 % | -324.337 K 86.80 % | -2.456 M |
| Capital expenditure | -9.469 K -656.51 % | -1.252 K 95.43 % | -27.397 K |
| Free CashFlow | -698.715 K -114.60 % | -325.588 K 86.89 % | -2.484 M |
| 2021 | 2020 | 2019 |
| 2022-04-30 | |
|---|---|
| Revenue | 199.787 K |
| Net income | -436.016 K |
| Income before tax | -184.106 K |
| Income before tax ratio | -0.92 |
| EBITDA | -480.436 K |
| Net income ratio | -2.18 |
| Ratio EBITDA | -2.40 |
| Gross profit ratio | 0.72 |
| Weighted average shs out dil | 100.664 M |
| Weighted average shs out | 100.664 M |
| EPS diluted | 0.00 |
| Earnings per share | 0.00 |
| Gross profit | 143.709 K |
| Income tax expense | 251.914 K |
| Cost of revenue | 56.078 K |
| General and administrative expenses | 358.155 K |
| Selling and marketing expenses | 3.343 K |
| Other expenses | 0.000 |
| Operating expenses | 284.649 K |
| Cost and expenses | 340.727 K |
| Research and development expenses | 0.000 |
| Selling general and administrative expenses | 361.498 K |
| Interest income | 0.000 |
| Interest expense | 55.534 K |
| Depreciation and amortization | 19.406 K |
| Operating income | -140.940 K |
| Operating income ratio | -0.71 |
| Total other income expenses net | -43.166 K |
| 2022-04-30 |
| 2022-04-30 | |
|---|---|
| Net debt | 1.895 M |
| Total investments | 3.931 M |
| Total debt | 1.910 M |
| Accumulated other comprehensive income loss | 204.087 K |
| Retained earnings | -4.460 M |
| Common stock | 6.925 M |
| Total equity | 2.669 M |
| Other non current liabilities | 0.000 |
| Long term debt | 328.234 K |
| Total non current liabilities | 328.234 K |
| Other current liabilities | 1.201 M |
| Deferred revenue | 16.810 K |
| Short term debt | 2.035 M |
| Total current liabilities | 2.928 M |
| Total liabilities | 3.256 M |
| Other non current assets | 0.435 |
| Long term investments | 3.931 M |
| Intangible assets | 150.564 K |
| GoodWill | 0.000 |
| Goodwill and intangible assets | 150.564 K |
| Property plant equipment net | 1.594 M |
| Total non current assets | 5.676 M |
| Other current assets | 3.542 K |
| Short term investments | 0.000 |
| cash and cash equivalents | 15.525 K |
| Cash and short term investments | 15.525 K |
| Total current assets | 250.013 K |
| Inventory | 167.774 K |
| Net receivables | 63.172 K |
| Tax assets | 0.565 |
| Other assets | 0.000 |
| Account payables | 586.467 K |
| Tax payables | 58.608 K |
| Deferred revenue non current | 0.000 |
| Minority interest | 0.000 |
| Capital lease obligations | 0.000 |
| Preferred stock | 0.000 |
| Other total stockholders equity | 759.653 K |
| Deferred tax liabilities non current | 0.000 |
| Other liabilities | 0.000 |
| Total assets | 5.926 M |
| 2022-04-30 |
| 2022-04-30 | |
|---|---|
| Deferred income tax | 43.345 K |
| Stock based compensation | 22.458 K |
| Change in working capital | 133.008 K |
| Accounts receivables | 24.018 K |
| Inventory | -35.186 K |
| Accounts payables | 115.784 K |
| Other working capital | 28.392 K |
| Other non cash items | 214.473 K |
| Net cash provided by operating activities | -3.325 K |
| Investments in property plant and equipment | 0.000 |
| Acquisitions net | 0.000 |
| Purchases of investments | 0.000 |
| Sales maturities of investments | 0.000 |
| Other investing activites | 0.000 |
| Net cash used for investing activites | 0.000 |
| Debt repayment | 0.000 |
| Common stock issued | 0.000 |
| Common stock repurchased | 0.000 |
| Dividends paid | 0.000 |
| Other financing activites | 2.000 |
| Net cash used provided by financing activities | 1.555 |
| Effect of forex changes on cash | 0.000 |
| Net change in cash | -3.549 K |
| Cash at beginning of period | 19.074 K |
| Cash at end of period | 15.525 K |
| Operating cash flow | -3.325 K |
| Capital expenditure | 0.000 |
| Free CashFlow | -3.325 K |
| 2022 |